3′-Deoxy-3′-fluoroguanosine exhibits antiviral activity against tick-borne encephalitis virus (TBEV), through interaction with NS5B RdRp of HCV , resulting in suppression of viral RNA synthesis by disruption of further extension of the replicating viral RNA.